Search
Drug targets identified through cell line to potentially treat rare pediatric cancer
- OPACC
- Jan 21, 2015
- 1 min read
A team of investigators at the Cumming School of Medicine have made key new findings about an extremely rare childhood cancer called neurocutaneous melanocytosis (NCM).
Recent Posts
See AllA Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic...
A pan-Canadian team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumors in...
Recent study results indicated that pediatric patients with acute lymphoblastic leukemia (ALL) were experiencing some motor skill impacts...